Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 4/2016

01-05-2016

Simplified PESI score and sex difference in prognosis of acute pulmonary embolism: a brief report from a real life study

Authors: Luca Masotti, Grazia Panigada, Giancarlo Landini, Filippo Pieralli, Francesco Corradi, Salvatore Lenti, Rino Migliacci, Stefano Arrigucci, Anna Frullini, Maria Chiara Bertieri, Stefano Tatini, Alberto Fortini, Irene Cascinelli, Nicola Mumoli, Stefano Giuntoli, Alessandro De Palma, Veronica De Crescenzo, Michele Piacentini, Giancarlo Tintori, Alba Dainelli, Giuseppa Levantino, Plinio Fabiani, Filippo Risaliti, Roberta Mastriforti, Michele Voglino, Valentina Carli, Simone Meini

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2016

Login to get access

Abstract

Prognostic stratification of acute pulmonary embolism (PE) remains a challenge in clinical practice. Simplified PESI (sPESI) score is a practical validated score aimed to stratify 30-day mortality risk in acute PE. Whether prognostic value of sPESI score differs according to sex has not been previously investigated. Therefore the aim of our study was to provide information about it. Data records of 452 patients, 180 males (39.8 %) and 272 females (60.2 %) discharged for acute PE from Internal Medicine wards of Tuscany (Italy) were analysed. sPESI was retrospectively calculated. Variables enclosed in sPESI score, all cause in-hospital mortality and overall bleedings were compared between sexes. Moreover, predictive ability of sPESI score as prognosticator of all cause in-hospital mortality was tested and compared between sexes. sPESI score 0 (low risk) was found in 17.7 % of males and 13.6 % of females (p = 0.2323). We didn’t find significant difference in sPESI scoring distribution. Age ≥80 years (51.4 vs. 33.8 %, p = 0.0003) and heart rate ≥110 bpm (23.5 vs. 14.4 %, p = 0.0219) were found significantly more prevalent in females, whereas active cancer (23.8 vs. 39.4 %, p = 0.0004) and cardio-respiratory diseases (19.8 vs. 27.7 %, p = 0.0416) were in males. All cause in-hospital mortality was 0 % in both genders for sPESI score 0, whereas it was 5.4 % in females and 13.6 % in males with sPESI score 1–2 (p = 0.0208) and 22 % in females and 19.3 % in males with sPESI score ≥3 (p = 0.7776). Overall bleedings were significantly more frequent in females compared with males (4.77 vs. 0.55 %, p = 0.0189). In females overall bleedings ranged from 2.7 % in sPESI score 0 to 6 % in sPESI score ≥3. Predictive ability of sPESI score as prognosticator of all cause in-hospital mortality was higher in females compared to males (AUC 0.72 vs. 0.67, respectively). In real life different co-morbidity burdens in females compared to males. Females seems to be at lower risk of all cause in-hospital mortality for sPESI score ≤2 but at higher risk of bleeding, irrespective from sPESI scoring. Predictive ability of sPESI score seems better in females.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jiménez D, Aujesky D, Moores L et al (2010) RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMed Jiménez D, Aujesky D, Moores L et al (2010) RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389CrossRefPubMed
2.
go back to reference Konstantinides S, Torbicki A, Agnelli G, Authors/Task Force Members et al (2014) ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069 Konstantinides S, Torbicki A, Agnelli G, Authors/Task Force Members et al (2014) ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS). Eur Heart J 2014(35):3033–3069
3.
go back to reference Masotti L, Pieralli F, Panigada G et al. (2015) Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE Study. Ital J Med 9:121–129CrossRef Masotti L, Pieralli F, Panigada G et al. (2015) Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE Study. Ital J Med 9:121–129CrossRef
4.
go back to reference Schulman S, Kearon C on behalf of the SubCommittee on Control of the Anticoagulation of the Scientific and Standardization Committee of the Intrnational Society of Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694CrossRefPubMed Schulman S, Kearon C on behalf of the SubCommittee on Control of the Anticoagulation of the Scientific and Standardization Committee of the Intrnational Society of Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3:692–694CrossRefPubMed
5.
go back to reference Blanco-Molina A, Enea I, Gadelha T et al (2014) RIETE Investigators. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism. Medicine 93:309–317CrossRefPubMedPubMedCentral Blanco-Molina A, Enea I, Gadelha T et al (2014) RIETE Investigators. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism. Medicine 93:309–317CrossRefPubMedPubMedCentral
6.
go back to reference Borrero S, Aujesky D, Stone RA, Geng M, Fine MJ, Ibrahim SA (2007) Gender differences in 30-day mortality for patients hospitalized with acute pulmonary embolism. J Womens Health 16:1165–1170CrossRef Borrero S, Aujesky D, Stone RA, Geng M, Fine MJ, Ibrahim SA (2007) Gender differences in 30-day mortality for patients hospitalized with acute pulmonary embolism. J Womens Health 16:1165–1170CrossRef
7.
go back to reference Lapner S, Cohen N, Kearon C (2014) Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis. J Thromb Haemost 12:595–605CrossRefPubMed Lapner S, Cohen N, Kearon C (2014) Influence of sex on risk of bleeding in anticoagulated patients: a systematic review and meta-analysis. J Thromb Haemost 12:595–605CrossRefPubMed
8.
go back to reference Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW (2015) Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified pulmonary embolism severity index score from a Post hoc analysis of the EINSTEIN PE study. Acad Emerg Med 22:299–307CrossRefPubMedPubMedCentral Fermann GJ, Erkens PM, Prins MH, Wells PS, Pap ÁF, Lensing AW (2015) Treatment of pulmonary embolism with rivaroxaban: outcomes by simplified pulmonary embolism severity index score from a Post hoc analysis of the EINSTEIN PE study. Acad Emerg Med 22:299–307CrossRefPubMedPubMedCentral
Metadata
Title
Simplified PESI score and sex difference in prognosis of acute pulmonary embolism: a brief report from a real life study
Authors
Luca Masotti
Grazia Panigada
Giancarlo Landini
Filippo Pieralli
Francesco Corradi
Salvatore Lenti
Rino Migliacci
Stefano Arrigucci
Anna Frullini
Maria Chiara Bertieri
Stefano Tatini
Alberto Fortini
Irene Cascinelli
Nicola Mumoli
Stefano Giuntoli
Alessandro De Palma
Veronica De Crescenzo
Michele Piacentini
Giancarlo Tintori
Alba Dainelli
Giuseppa Levantino
Plinio Fabiani
Filippo Risaliti
Roberta Mastriforti
Michele Voglino
Valentina Carli
Simone Meini
Publication date
01-05-2016
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 4/2016
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-015-1260-0

Other articles of this Issue 4/2016

Journal of Thrombosis and Thrombolysis 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.